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Abstract
Lipopolysaccharide (LPS) is the major pathogen-associated molecular pattern of Gram-
negative bacterial infections, and includes smooth (S-LPS) and rough (R-LPS) chemotypes.
Upon activation by LPS through CD14, TLR4/MD-2 heterodimers sequentially induce two
waves of intracellular signaling for macrophage activation: the MyD88-dependent pathway
from the plasma membrane and, following internalization, the TRIF-dependent pathway
from endosomes. We sought to better define the role of scavenger receptors CD36 and
CD204/SR-A as accessory LPS receptors that can contribute to pro-inflammatory and
microbicidal activation of macrophages. We have found that CD36 differently regulates acti-
vation of mouse macrophages by S-LPS versus R-LPS. The ability of CD36 to substitute for
CD14 in loading R-LPS, but not S-LPS onto TLR4/MD-2 allows CD14-independent macro-
phage responses to R-LPS. Conversely, S-LPS, but not R-LPS effectively stimulates CD14
binding to CD36, which favors S-LPS transfer from CD14 onto TLR4/MD-2 under conditions
of low CD14 occupancy with S-LPS in serum-free medium. In contrast, in the presence of
serum, CD36 reduces S-LPS binding to TLR4/MD-2 and the subsequent MyD88-depen-
dent signaling, by mediating internalization of S-LPS/CD14 complexes. Additionally, CD36
positively regulates activation of TRIF-dependent signaling by both S-LPS and R-LPS, by
promoting TLR4/MD-2 endocytosis. In contrast, we have found that SR-A does not function
as a S-LPS receptor. Thus, by co-operating with CD14 in both R- and S-LPS loading onto
TLR4/MD-2, CD36 can enhance the sensitivity of tissue-resident macrophages in detecting
infections by Gram-negative bacteria. However, in later phases, following influx of serum to
the infection site, the CD36-mediated negative regulation of MyD88-dependent branch of
S-LPS-induced TLR4 signaling might constitute a mechanism to prevent an excessive
inflammatory response, while preserving the adjuvant effect of S-LPS for adaptive
immunity.
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Introduction
Macrophages and other sentinel cells detect infections with the use of pattern recognition
receptors, which specifically recognize compounds produced by entire groups of related patho-
gens, by not by host cells, the so-called pathogen-associated molecular patterns (PAMPs).
Lipopolysaccharide (LPS), a component of the outer membrane of Gram-negative bacteria, is
the major PAMP signifying infections caused by these pathogens. It is recognized through the
heterodimer of Toll-like receptor 4 (TLR4) with the secreted protein MD-2 [1]. LPS binding
induces dimerization of TLR4/MD-2/LPS complexes, which allows dimerization of intracellu-
lar Toll/IL-1 receptor (TIR) domains of TLR4 and their binding to TIR domains present in
adaptor proteins [2]. TLR4 is unique among TLRs as it engages all four adaptors involved in
TLR signaling and sequentially initiates two distinct signal transduction pathways. In the
plasma membrane, TLR4 induces signaling mediated by the adaptor pair TIRAP/MyD88,
which leads to the early activation of NF-κB transcription factor and of mitogen-activated pro-
tein kinases and production of pro-inflammatory cytokines, such as tumor necrosis factor
(TNF)-α [3]. Subsequently, TLR4/MD-2/LPS complexes undergo dynamin-dependent endocy-
tosis through clathrin-coated pits, and within endosomes they induce the second wave of sig-
naling, mediated by the adaptor pair TRAM/TRIF [4–6]. This TRIF-dependent pathway
mediates activation of interferon-regulatory factor 3 and delayed activation of NF-κB, and is
responsible for the induction of the majority of LPS-inducible genes, including type I interfer-
ons, interferon-inducible genes and some chemokines, such as RANTES [4, 7].
As the biologically active part of LPS (lipid A) is hydrophobic, its efficient binding to TLR4/
MD-2 requires assistance from accessory proteins, containing hydrophobic domains which
bind lipid A and prevent its thermodynamically unfavorable interactions with the polar envi-
ronment. The best characterized pair of such proteins is represented by soluble LPS-binding
protein (LBP) from serum and CD14, a protein attached to the plasma membrane through a
glycosylphosphatidylinositol (GPI) anchor. LBP binds to LPS micelles or to surfaces of bacteria
and catalyzes extraction and transfer of LPS monomers onto CD14, which, in turn, serves as
the direct LPS donor for TLR4/MD-2 [8, 9]. In addition to its role in sensitizing TLR4/MD-2
to activation by very low (picomolar) concentrations of LPS, the involvement of CD14 is
required for the activation of TRIF-dependent signaling, due to its role in mediating internali-
zation of TLR4/MD-2/LPS complexes. This internalization was found independent of TLR4
signaling and to involve the Syk tyrosine kinase-dependent activation of phospholipase Cγ2
and calcium mobilization from intracellular stores [10–12].
The LPS molecule consists of phosphorylated diglucosamine substituted with 4–7 chains of
long fatty acids, known as lipid A, which anchors the molecule to the membrane, to which the
polysaccharide part of a varied size is attached. The polysaccharide is comprised of a more con-
served core oligosaccharide, directly linked to lipid A, and the so-called O-antigen, built of
units containing 3–8 glycosyl residues and repeated up to even more than 100-times. As the
presence of the O-antigen in LPS is not essential for the viability of bacteria, but its synthesis is
energy-demanding, in the absence of the selection pressure from the immune system some bac-
teria, in particular Enterobacteriaceae, cease to decorate their LPS with O-antigens [13]. LPS
lacking the O-antigen is called rough LPS (R-LPS), because of the rough morphology of bacte-
rial colonies producing it, as opposed to smooth appearing colonies of bacteria producing O-
antigen-containing smooth LPS (S-LPS). R- and S-LPS have been often indiscriminately used
in experiments. However, recent results have revealed that different LPS chemotypes may differ
markedly in biological effects, likely as the result of differences in receptor usage. In particular,
the involvement of CD14 is obligatory for the activation of MyD88-dependent pathways of
TLR4 signaling by S-LPS, but not by R-LPS [10, 14].
CD36 Regulates Macrophage Responses to LPS
PLOSONE | DOI:10.1371/journal.pone.0153558 April 13, 2016 2 / 26
Competing Interests: The authors have declared
that no competing interests exist.
In addition to LBP and CD14, several other proteins have been suggested to function as LPS
uptake or accessory signaling receptors, including the class B scavenger receptor (SR)–CD36,
and the class A SR–SR-A/CD204. Baranova et al. reported that CD36 is a signaling receptor for
LPS, mediating the c-Jun N-terminal kinase (JNK)-dependent production of pro-inflammatory
cytokines in response to both R-LPS and S-LPS [15]. These results are inconsistent with several
other reports in which no effect of CD36-deficiency on macrophage responses to LPS was
observed [16–18]. The role of CD36 as an autonomously signaling LPS receptor is further
refuted by our observation that macrophages from C3H/HeJ mice, with a loss of function
mutation in the TLR4 gene [9], fail to produce inflammatory cytokines in response to even
very high concentrations of LPS (20 μg/ml), despite responding normally to CD36 ligands
[19].
SR-A is able to bind lipid IVA, the tetraacylated precursor of lipid A, lipid A itself and deep
rough (Re) LPS, in which the polysaccharide component is truncated to 2–3 KDO (3-deoxy-α-
D-mannooctulosonic acid) residues attached to lipid A [20–22]. In contrast, there are conflict-
ing observations regarding the role of SR-A as a receptor for natural LPS. Peiser et al. have
demonstrated that LPS does not serve as the specific SR-A ligand on the surface of Gram-nega-
tive bacteria [23]. We did not observe any differences between WT and SR-A-/- macrophages
in the binding of a wide range of concentrations (0.1–10 μg/ml) of biotinylated S-LPS (bS-LPS)
[19]. Likewise, Drummond et al. have demonstrated that SR-A does not bind 10 μg/ml bS-LPS
[24]. In contrast, SR-A has been reported to be the major macrophage receptor for uptake of
fluorescent conjugates of LPS [25–27].
Acetylated low density lipoproteins, used at concentrations that block SR-A, could not alter
lipid IVA or Re-LPS stimulation of TNF-α release [20], indicating that SR-A does not serve as
a signaling receptor for these LPS precursors/partial structures. We have observed that SR-A
deficiency has no effect on TNF-α, RANTES, IL-10 and IL-6 production, stimulated by 0.1–
1 μg/ml S-LPS in murine peritoneal exudate macrophages (PEMs) [19]. Others reported unal-
tered S-LPS-stimulated chemokine production in SR-A-/- resident peritoneal macrophages
[28]. In contrast, it has been suggested in four recent reports that SR-A participates in macro-
phage activation by S-LPS. However, these reports appear to be mutually conflicting [24, 27,
29, 30]. Moreover, they are difficult to reconcile with our observations that SR-A does not
serve as a S-LPS receptor and that SR-A ligation with acetylated low density lipoproteins or
specific mAb has no effect on LPS-stimulated TNF-α and RANTES production in macro-
phages [19].
In this study, we have assessed the role of CD36 and SR-A as receptors for S-LPS and for
R-LPS of the Ra-type, which lacks the O-antigen, but contains the complete core structure
[31]. Our results have revealed that, like CD14, CD36 plays disparate roles in regulating macro-
phage responses to S-LPS versus R-LPS. In contrast, SR-A does not seem involved in either
uptake or signaling by S-LPS.
Materials and Methods
Reagents
Ultrapure: LPS from Escherichia coli K12 strain (R-LPS), LPS from E. coli 0111:B4 (S-LPS), bio-
tinylated S-LPS (bS-LPS) and lipoteichoic acid from Staphylococcus aureus (LTA) were pur-
chased from InvivoGen. Bovine serum albumin (BSA) was obtained from Roche Diagnostics,
delipidated, low-endotoxin BSA, dextran sulfate (DS, MW ~500 kDa), chondroitin sulfate
from bovine trachea, cytochalasin D and hydroxy-dynasore from Sigma-Aldrich and the JNK-
selective inhibitor SP600125 from Tocris.
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Mouse anti-mouse CD36 mAb (clone CRF D-2712) was provided by Hycult Biotech; rat
anti-mouse TLR4/MD-2 complex (clones: MTS510 and Sa15-21) and rat IgG2a isotype control
(RTK2758) mAb by BioLegend; rat anti-mouse TLR2 (T2.5) mAb by eBioscience; rat anti-
mouse CD14 (4C1/CD14), rat anti-mouse CD11b/CR3 (M1/70), mouse IgA isotype control
(M18-254) and rat IgG2b isotype control (A95-1) mAbs by BD Biosciences. With the exception
of mouse IgA, the antibodies were functional grade purified (low endotoxin/no azide).
Glycolaldehyde-modified BSA (GA-BSA) was prepared, as described previously [32].
The conjugate of streptavidin with pHrodo Red (pHr-SAV) was prepared by adding 32 μl of
10.2 mM solution of pHr succinimidyl ester (Invitrogen) in dimethyl sulfoxide to 0.97 ml of
streptavidin (Vector Laboratories), dissolved at 1.03 mg/ml in 0.1 M sodium bicarbonate (pH
8.4). Following 15-min incubation, unconjugated dye was separated by extensive dialysis.
Mice
Breeding pairs of SR-A-deficient and CD36-deficient mice, both on the C57BL/6 background,
as well as wild-type (WT) C57BL/6 mice were purchased from the Jackson Laboratory. Mice
were housed in our facility in microisolator cages with filter tops on a 12-h light/dark cycle.
This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the Ministry of Science and Information of Poland.
The protocol was approved by the I Local Committee on the Ethics of Animal Experiments of
Jagiellonian University (permit number: 83/2009). All surgery was performed under isoflurane
(Abbott Laboratories) anesthesia, and all efforts were made to minimize suffering. A total of
147 mice were used in the experiments.
Macrophages
Mice were quickly euthanized by overdose with isoflurane vapor, followed by cervical disloca-
tion. Inflammatory peritoneal cells, elicited with 1.5 ml of 3% Thioglycollate (Difco Laborato-
ries), injected i.p. 4 days earlier, were washed out with phosphate-buffered saline (PBS). The
cells were re-suspended at 0.8 × 106 in FCS-RPMI [RPMI 1640 medium with HEPES, supple-
mented with 10% fetal calf serum (FCS), 2 mM L-glutamine (Cytogen), and 0.04 mg/ml genta-
mycin (KRKA)] and, unless otherwise indicated, plated at 1.6 × 105/well in 96-well tissue
culture-treated plates. After overnight incubation, non-adherent cells were removed by wash-
ing and adherent macrophages (PEM) were used in the experiments described below.
Binding and uptake of bS-LPS
Binding. Adherent PEMs were incubated for 1 h on ice with bS-LPS in FCS-RPMI, as
described previously [19]. Subsequently, the cells were washed 3 times with 0.5% BSA in PBS
(BSA-PBS) and incubated for another 1 h with 5 μg/ml horseradish peroxidase-streptavidin
conjugate (HRP-SAV, Vector Laboratories) in BSA-PBS. Following extensive washing, the
enzymatic reaction for peroxidase was performed with the use of TMB Substrate Reagent Set
(BD Biosciences) as the substrate. The absorbance of the product was measured in a plate
reader (PowerWave, Bio-Tek Instruments). Alternatively, PEMs were incubated with 5 μg/ml
phycoerythrin-SAV conjugate (eBioscience), instead of HRP-SAV, and cell-associated fluores-
cence was quantified in a fluorescence plate reader (Infinite M200 PRO, Tecan).
Uptake. PEMs were incubated for 1 h on ice with 0.2 or 2 μg/ml bS-LPS, as described
above. Following washing, 60 μl/well of 10 μg/ml pHr-SAV in BSA-PBS was added for 50-min
incubation on ice. Subsequently, the cells were washed 3 times, 0.14 ml of FCS-RPMI was
added and the plates were placed for 100 min in a cell culture incubator. Finally, the wells were
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washed once, filled with 0.1 ml PBS which pH was adjusted to 9.0 with 25 mMHEPES, and the
fluorescence of PEMs was quantified in the fluorescence plate reader.
Binding assays with recombinant receptors
Preparation of coated plates. Ninety six-well, half area ELISA plates (Corning Inc.) were
coated by overnight incubation at 4–8°C with 45 μl of PBS containing 5 μg/ml of recombinant
mouse receptors (R&D Systems), 20 μg/ml GA-BSA or 50 μg/ml LPS or LTA. The plates were
washed twice with 0.05% Tween 20 in PBS or BSA-PBS (LPS- or LTA-coated plates), blocked
for 1 h at room temperature with 150 μl/well of 10% FCS in PBS (FCS-PBS) or 2% BSA in PBS
(LPS- or LTA-coated plates), washed again and used in the experiments described below.
Levels of adsorption of receptors to plates were compared by a direct ELISA method, with
the use of 2.5 μg/ml of HRP-conjugated F(ab’)2 fragments of goat antibodies specific for Fc
fragments of human IgG (HRP-anti-Fc, Rockland), as recombinant receptors we used were
tagged with the Fc fragment of human IgG1.
Binding of bS-LPS. Different concentrations of bS-LPS in FCS-PBS or BSA-PBS were
added in 45 μl to plates coated with recombinant receptors for 80-min (rCD36) or 1-h (rCD14,
rLBP) incubation at 37°C. Subsequently, the plates were washed 4 times with BSA-PBS and
incubated for 30 min at 37°C with 4 μg/ml of HRP-SAV in BSA-PBS. Following 6-times wash-
ing, the enzymatic reaction for peroxidase was performed. In parallel, non-specific binding to
wells not coated with receptors was determined for each bS-LPS concentration and subtracted
from the total binding to receptor-coated wells to obtain the receptor-specific binding.
bS-LPS transfer between receptors. rCD36 adsorbed to ELISA plates was loaded with
bS-LPS by 80-min incubation at 37°C with 45 μl of 500 ng/ml bS-LPS in BSA-PBS. Similarly,
plate-adsorbed rCD14 and rLBP were loaded with 250 ng/ml bS-LPS in, respectively, FCS-PBS
and BSA-PBS. After washing 4 times with BSA-PBS, 90 μl/well of 5 μg/ml recombinant recep-
tors or other potential LPS acceptors was added for 1-h incubation at 37°C. Following washing,
bS-LPS that remained bound to immobilized receptors was detected with HRP-SAV, as
described above.
Direct binding between receptors. Plate-adsorbed receptors were incubated for 90 min at
37°C with different concentrations of soluble receptors, with or without 1 μg/ml LPS, in 60 μl
FCS-PBS. Subsequently, the plates were washed 4-times with BSA-PBS. Bound rCD36 was
detected by 1-h incubation with 2 μg/ml of polyclonal goat anti-mouse CD36 Ab (R&D Sys-
tems), followed by 1-h incubation with 4 μg/ml of HRP-conjugated F(ab’)2 fragments of don-
key anti-goat IgG Ab (Rockland) in BSA-PBS. Bound rLBP was detected with 1:400 dilution of
HRP-conjugated mouse monoclonal IgG1 anti-6×Histidine (R&D Systems).
Competition experiments with rCD36. rCD36 (2 μg/ml) was pre-incubated for 20 min at
37°C with competitors (100 μg/ml DS or CS, 5 μg/ml anti-CD36 or control IgA mAb, 200 μg/
ml LTA or LPS), before being added to GA-BSA-coated plates for 60-min incubation at room
temperature. Subsequently, plates were washed 3 times with Tween/PBS and bound rCD36
was detected by 50-min incubation with 2 μg/ml of HRP-anti-Fc in BSA-PBS. Binding of
rCD36 to LPS- or LTA-coated plates was assessed in a similar manner, except that BSA-PBS,
instead of Tween/PBS was used as the washing buffer.
Binding and uptake of fluorescently-labeled S-LPS
Fluorescent LPS. A conjugate of oxidized S-LPS with the Alexa Fluor 647 fluorescent dye
(AF-LPS) was prepared as follows. S-LPS was suspended at 1 mg/ml in 0.5 ml of 0.1 M sodium
acetate (pH 5.0) and incubated with 1 mM sodium metaperiodate (Sigma-Aldrich) for 30 min
on ice [33]. The reaction was stopped by adding 4 μl of glycerol and oxidized LPS was separated
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from other reagents by extensive, 24-h dialysis against PBS at 4°C (6–8 kDa cutoff). Fifty μl of
Alexa Fluor 647 hydrazide (Invitrogen), dissolved at 50 mM in dimethyl sulfoxide, was added
to 0.5 ml of LPS for 2-h incubation at room temperature. Unreacted dye was separated by dial-
ysis. The estimated degree of labeling in this AF-LPS preparation was ~0.47:1 (AF:S-LPS).
To prepare a conjugate of native S-LPS with BODIPY FL (BO-LPS), S-LPS was suspended
at 2 mg/ml in 0.25 ml of PBS, sonicated and mixed with 25 μl of 50 mM BODIPY FL hydrazide
(Invitrogen) in dimethyl sulfoxide. After 40-min incubation at 37°C, the mixture was sonicated
again, 0.2 ml of 0.2 M NaHCO3, (pH 8.7) and another 25 μl of BODIPY FL hydrazide were
added and the incubation was continued for further 1 h. The sample was then microfuged and
the supernatant dialyzed. The estimated degree of labeling in BO-LPS was ~0.13:1.
Uptake. PEMs were incubated for 70 min at 37°C in 0.16 ml FCS-RPMI, containing the
indicated concentrations of fluorescently-labeled LPS preparations. Then, the cells were
washed 3-times with PBS and their fluorescence was measured in the fluorescence plate reader
or by flow cytometry, following detachment with lidocaine/EDTA [34].
Binding. In the binding experiments, PEMs were metabolically-poisoned by 30-min incu-
bation at 37°C with 80 μl of PBS with Ca/Mg, containing 1 mMNaN3, 2 mM NaF and 50 mM
2-deoxyglucose (Sigma-Aldrich), in order to prevent internalization of bound ligands. Subse-
quently, 80-μl volumes of 20% FCS in Ca/Mg-PBS, containing double-concentrated solutions
of fluorescent ligands, were added and the incubation was continued for 70 min. The rest of
the procedure was the same as in the uptake experiments.
Binding of rCD14 to PEMs
PEMs were pre-incubated for 40 min at 37°C with 20% mouse serum in FCS-RPMI. Subse-
quently, the medium was replaced with 30 μl of double-concentrated solutions of receptor-
blocking mAb in FCS-RPMI for 30 min pre-incubation at room temperature, followed by addi-
tion of 30 μl of double-concentrated solution of rCD14 (the final concentration 5 μg/ml), with
or without LPS, and incubation at 37°C for 50 min. The cells were washed 4-times with ice-
cold BSA-PBS and incubated for 50 min on ice with 2.5 μg/ml of HRP-anti-Fc. After extensive
washing, the enzymatic reaction for peroxidase was performed.
Stimulation of cytokine production
Peritoneal exudate cells were plated at 1.12 × 105/well. PEMs were incubated for 1 h on ice with
1 μg/ml LPS or for 40 min at 37°C with 200 ng/ml LPS in 0.14 ml FCS-RPMI or serum-free
medium (BSA-RPMI), containing 0.5% low-endotoxin BSA instead of FCS. Subsequently,
unbound LPS was removed by washing 2-times with PBS, 0.14 ml of fresh FCS-RPMI was
added and the incubation was continued for 3 h in a cell culture incubator. To block CD14 or
TLR4/MD-2, the cells were pre-incubated for 30 min at room temperature with 70 μl of dou-
ble-concentrated solutions of mAb (40 μg/ml), before the same volume of LPS-containing
medium was added. Pre-incubated with pharmacological inhibitors was performed at 37°C for
30 min. Cytokine concentrations in culture supernatants were determined by ELISA, as
described previously [19].
Monomeric S-LPS/rCD14 complexes were prepared by an overnight incubation at 37°C of
2 μg/ml S-LPS with 50 μg/ml rCD14 (R&D Systems) in BSA-PBS [35].
Assessment of LPS binding to TLR4/MD-2
For assessing the degree of TLR4/MD-2 occupancy by LPS, we exploited the ability of LPS to
inhibit binding of clone MTS510 anti-TLR4/MD-2 mAb to the receptor complex [36] in cellu-
lar ELISA [37]. PEMs were incubated for 40 min at 37°C with 200 ng/ml of S-LPS or R-LPS in
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0.2 ml FCS-RPMI or BSA-RPMI. The cells were washed once with PBS and incubated for 20
min on ice with 40 μl of 40% mouse serum in FCS-RPMI. Subsequently, 40 μl of double-con-
centrated solutions of MTS510 or control rat IgG2a mAb was added (the final concentration
5 μg/ml) and the incubation was continued for 1 h. Unbound mAb were removed by 3-times
washing with ice-cold BSA-PBS and PEMs were subjected to another 50-min incubation on ice
with 5 μg/ml of HRP-conjugated F(ab’)2 fragments of goat Ab anti-rat IgG, pre-adsorbed with
mouse serum proteins (Rockland) in 70 μl of FCS-RPMI. The wells were washed 6-times and
the enzymatic reaction for peroxidase was performed, as described above. The specific binding
was calculated by subtracting binding of control rat IgG2a from the total binding of MTS510
mAb. In parallel, the effect of each treatment on cell surface expression of TLR4/MD-2 was
determined with the use of clone Sa15-21 mAb, which binding to TLR4/MD-2 is unaffected by
LPS [36], and used for the normalization of data.
Data analysis
The data were analyzed with the Student’s t-test, for single comparisons, or ANOVA, for multi-
ple comparisons, with the Tukey-Kramer post-test used to compare all pairs of groups, and the
Dunnett’s test to compare all other groups to the control group (GraphPad Prism software).
The p values< 0.05 were assumed to denote statistically significant difference. The GraphPad
Prism program was also used to calculate receptor binding parameters by non-linear regression
curve fitting.
Results
Binding of S-LPS to PEMs is mediated by CD14, but not by CD36 or
SR-A
PEMs exhibited dose-dependent, saturable binding of bS-LPS (KD ~190 ng/ml) during 1-h
incubation on ice in serum-containing medium (Fig 1A). This binding was prevented by block-
ing anti-CD14 mAb, but was not significantly affected by CD36 or SR-A deficiency (Fig 1B).
Likewise, bS-LPS binding to metabolically poisoned PEMs at 37°C was strongly inhibited by
anti-CD14 mAb (Fig 1C), but unaffected by CD36 or SR-A deficiency (S1A Fig). However,
anti-CD14 mAb consistently produced stronger inhibition of bS-LPS binding on ice than at
37°C. Binding of bS-LPS to PEMs, both at 37°C (Fig 1C) and on ice (S1B Fig), was also blocked
by 200-250-fold excess of unlabeled S-LPS, confirming that S-LPS itself rather than the
attached biotin is responsible for bS-LPS binding to PEMs.
In serum-free medium (BSA-PBS), bS-LPS bound to rCD14 with a KD of 113 ± 20.9 ng/ml
(mean ± SEM from 6 experiments, S2A Fig). The inclusion of serum produced a ~3-fold
increase of the maximal bS-LPS binding to rCD14 (S2A Fig), but the affinity of binding did not
significantly change (KD = 87 ± 16.0 ng/ml, N = 4). Lower bS-LPS binding to rCD14 in serum-
free, as compared to serum-containing medium during 1-h incubation was caused by much
slower binding kinetics (S2B Fig). LBP seems to be the serum component responsible for the
acceleration of bS-LPS binding to rCD14, because the addition of 200 ng/ml rLBP to BSA-PBS
increased the 1-h binding to levels even exceeding those observed in the presence of serum
(S2C Fig). No further increase of the binding was produced by higher concentrations of rLBP
(S2E Fig).
In experiments aimed to elucidate the mechanism of the enhancing effect of rLBP on
bS-LPS binding to rCD14, we have found that rLBP is able to bind bS-LPS, but with slightly
lower affinity (KD = 189 ± 16.9 ng/ml, N = 3; S2D Fig) than rCD14. rLBP-bound bS-LPS may
be then transferred to rCD14 (Fig 2A). Interestingly, this transfer is reversible, as indicated by
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the decrease of the amount of bS-LPS bound to rCD14 caused by post-incubation with rLBP
(Fig 2B). There was a weak binding between rLBP and rCD14, which was only significant at
rLBP concentrations higher than that sufficient to produce the maximal acceleration of bS-LPS
binding to rCD14 (Fig 2C). This low-affinity binding may reflect transient association between
rCD14 and rLBP, required for the transfer of S-LPS between these proteins.
rCD36 exhibited dose-dependent binding of bS-LPS, but binding of physiologically relevant
concentrations of bS-LPS (<500 ng/ml) was only observed in BSA-PBS, but not in FCS-PBS
(Fig 2D). Binding of bS-LPS to rCD36 was inhibited in ~74% by anti-CD36 mAb (S3A Fig).
However, the affinity of bS-LPS binding to rCD36 (KD = 837 ± 18.8 ng/ml, N = 3) was
~7.4-times lower than that to rCD14. Also the value of maximal binding was ~2.4-fold lower in
the case of rCD36. Consequently, even in BSA-PBS, binding of bS-LPS to rCD36 was very low
relative to that to rCD14 (S2A Fig); also under serum free conditions there was no difference in
bS-LPS binding at 37°C between metabolically-poisoned WT and CD36-/- PEMs (S1A Fig).
The difference in bS-LPS binding to rCD36 versus rCD14 was not caused by different amounts
of receptors adsorbed to plates (S3B Fig).
We also assessed the role of CD36 as a receptor for S-LPS and LTA in competition experi-
ments with soluble rCD36. In the presence of serum, binding of rCD36 to plate-adsorbed
GA-BSA was strongly inhibited by 0.2 mg/ml LTA, whereas the same concentration of S-LPS
had no effect (Fig 2E). In contrast, in serum-free medium S-LPS inhibited rCD36 binding to
GA-BSA to a similar extent as LTA. rCD36 binding to GA-BSA was also inhibited by anti-
CD36 mAb and DS, but not by chondroitin sulfate, a control polyanion which does not bind to
SRs (Fig 2E).
Incubation of bS-LPS/rCD36 complexes with serum decreased the amount of bS-LPS
bound to rCD36 by ~50% (Fig 2F), which may explain the apparent lack of bS-LPS binding to
rCD36 in serum-containing medium. However, our results do not support the role of LBP or
CD14 as the serum component mediating bS-LPS depletion from rCD36, as recombined recep-
tors or blocking mAb had little or no effect on the amount of bS-LPS bound to rCD36 (Fig 2F).
Fig 1. Binding of S-LPS to PEMs in serum-containingmedium is mediated by CD14. (A) bS-LPS binds dose-dependently to WT PEMs. (B) WT, CD36-/-
and SR-A-/- PEMs exhibit similar binding of bS-LPS, which is fully blocked by anti-CD14 mAb. (C) Binding of bS-LPS at 37°C to metabolically poisoned
PEMs is inhibited by anti-CD14 mAb and by an excess of unlabeled S-LPS. Graphs show averages +SEM from 3 independent experiments (B) or results of
single experiments, performed in 4 replicates, each representative of 3 such experiments performed (A, C). *, significant inhibition of bS-LPS binding
(p<0.05), according to Student’s t-test (B) or ANOVA, followed by the Dunnett’s post-test (C); A.U., arbitrary units.
doi:10.1371/journal.pone.0153558.g001
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CD36, but not SR-A participates in S-LPS uptake by PEMs
In order to assess the role of SR-A and CD36 in the uptake of S-LPS by PEMs, we examined
effects of receptor deficiencies on the uptake of Alexa Fluor 647-labeled S-LPS (AF-LPS). Rela-
tive to WT controls, in both SR-A-/- and CD36-/- PEMs uptake of 1–5 μg/ml AF-LPS was
decreased by ~21–25% (S4A Fig). Consistent with the major role of SRs, the uptake of AF-LPS
was reduced in ~62% by 0.1 mg/ml DS (S4B Fig). We then assessed AF-LPS binding to meta-
bolically-poisoned PEMs. As shown in S4C Fig, pre-incubation with NaN3, NaF and 2-deoxy-
glucose blocked internalization into acidic endosomes of pHr-labeled, HOCl-oxidized
ovalbumin (pHr-OVA-Cl), a ligand of both SR-A and CD36 [34], which confirms the effective-
ness of this treatment in blocking endocytosis. The binding of AF-LPS to metabolically-
Fig 2. The role of CD36 as a S-LPS receptor. (A) Incubation with 5 μg/ml rCD14, but not with rCD36 partially removes bS-LPS from rLBP. (B) rLBP, but not
rCD36 or serum depletes rCD14 of bound bS-LPS. (C) rLBP binds very weakly to plate-adsorbed rCD14, but not to rCD36 and this binding is only slightly
increased by 1 μg/ml S-LPS. (D) bS-LPS binds much more strongly to plate-adsorbed rCD36 in BSA-PBS than in FCS-PBS. (E) rCD36 binding to plate-
adsorbed GA-BSA is inhibited by 0.2 mg/ml LTA, 0.1 mg/ml DS and anti-CD36 mAb, whereas 0.2 mg/ml S-LPS inhibits rCD36 binding only in the absence of
serum. Chondroitin sulfate (CS) and control IgA have no effect on the binding. (F) A large portion of bS-LPS bound to rCD36 is removed by serum component
(s) distinct from CD14 or LBP. (G) Relative to WT controls, internalization of bS-LPS/pHr-SAV complexes is significantly decreased in CD36-/-, but not
SR-A-/- PEMs. Graphs showmeans ± SEM of 3–5 replicates, obtained in single experiments, each representative of at least 3 similar experiments performed
(A-F) or averages + SEM from 4 independent experiments (G). Data were analyzed with the regular (A, B, E and F) or repeated measures (G) ANOVA,
followed by the Dunnett’s post-test. *, p < 0.05; OD, optical density.
doi:10.1371/journal.pone.0153558.g002
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poisoned PEMs was several-fold lower than its uptake, indicating that AF-LPS becomes endo-
cytosed (S4B Fig). However, unlike bS-LPS binding, both the uptake and the binding of
AF-LPS were not saturable and increased linearly up to 5 μg/ml AF-LPS (S4D Fig). Moreover,
neither the uptake nor the binding of AF-LPS were inhibited by as high as 250-fold excess of
unlabeled S-LPS (S4B Fig). These results indicate that AF-LPS binding to PEMs is mediated by
the attached fluorochrome (AF) rather than by S-LPS itself.
A shared feature of SR ligands is their net negative charge. A strong negative charge is con-
ferred on the Alexa Fluor 647 molecule by 4 sulfite groups. We therefore prepared a weakly-
labeled conjugate of native, unoxidized S-LPS with an uncharged fluorescence dye–BODIPY
FL (BO-LPS) and assessed its uptake by PEMs. In CD36-/-, but not in SR-A-/- PEMs uptake of
BO-LPS was significantly decreased (S4E Fig). However, 200-fold access of unlabeled S-LPS
produced only partial, ~32% inhibition of BO-LPS uptake (S4F Fig). These results indicate that
BO-LPS uptake by PEMs is mediated by both S-LPS itself and by the attached FL BODIPY dye.
The above results question the usefulness of fluorescent LPS conjugates and suggest that the
observed in the previous studies binding of such conjugates to SR-A [25–27] might be an arti-
fact caused by the attached, negatively-charged fluorochromes. We therefore resorted to study-
ing uptake of bS-LPS, which, as shown above (Fig 1C), retains binding specificity of native
S-LPS. In these experiments, bS-LPS bound to CD14 on the surface of PEMs was labeled with
pHr-SAV and then the cells were incubated for 100 min at 37°C, in order to enable internaliza-
tion of bS-LPS/pHr-SAV complexes. As shown in Fig 2G, in CD36-/-, but not in SR-A-/-
PEMs internalization of bS-LPS into acidic endosomes was strongly reduced (by ~47%).
Binding of S-LPS to CD14 induces its association with CD36, not
accompanied by S-LPS transfer
The results obtained so far indicate that although S-LPS binding to PEMs in serum-containing
medium is mediated by CD14 but not CD36, CD36 co-operates with CD14 in S-LPS endocyto-
sis. Two mechanisms of this cooperation seemed possible to us. First, CD14 may transfer
S-LPS onto CD36, which then mediates S-LPS internalization. Alternatively, S-LPS binding to
CD14 induces its association with CD36 and both receptors are internalized together. The fact
that S-LPS binds to CD14 with much higher affinity than to CD36 makes the transfer of S-LPS
from CD14 to CD36 thermodynamically unfavorable. Consistently, we observed no transfer of
bS-LPS from rCD14 to rCD36 (Fig 2B).
We started testing the second model, assuming S-LPS-induced association of CD14 with
CD36, by examining the ability of rCD14 to bind to rCD36 and the influence of S-LPS on this
interaction. As a negative control we studied association of rCD36 with rRAGE, which, like
rCD14 and rCD36, was tagged with the Fc fragment of human IgG1. Only very weak binding
of rCD36 to plate-adsorbed rRAGE could be detected, which may be considered as non-spe-
cific binding (Fig 3A). In comparison to rRAGE-rCD36 interactions, rCD36 exhibited slightly
increased binding to rCD14, but only at rCD36 concentrations 5 μg/ml. However, the inclu-
sion of 1 μg/ml S-LPS stimulated strong binding between rCD36 and rCD14, which was
already evident at the lowest tested concentration of rCD36 (0.5 μg/ml) (Fig 3A). We then
assessed interactions of rCD14 with endogenous receptors expressed on the surface of PEMs.
In the absence of LPS, rCD14 exhibited only low-level binding to PEMs (Fig 3B). The inclusion
of S-LPS produced >25-fold increase of rCD14 binding to PEMs. Even higher (~2-fold)
rCD14 binding to PEMs was observed during incubation on ice (S1C Fig), suggesting that at
37°C a portion of PEM-bound rCD14 may undergo internalization. The S-LPS-stimulated
rCD14 binding to PEMs was selectively and almost completely inhibited by anti-CD36 mAb,
whereas blocking mAb against TLR2 or TLR4/MD-2 were ineffective (Fig 3C). The exclusive
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role of CD36 in mediating rCD14 binding to PEMs was confirmed in experiments with
CD36-deficient PEMs, which exhibited neither basal nor S-LPS-stimulated rCD14 binding
(Fig 3B).
In the presence of serum, CD36 reduces S-LPS-induced,
MyD88-dependent TLR4 signaling by competing with TLR4/MD-2 for
S-LPS/CD14 complexes
In order to assess functional consequences of S-LPS/CD14 binding to CD36, WT and knockout
PEMs were incubated with 1 μg/ml S-LPS for 1 h on ice. Subsequently, unbound S-LPS was
washed out and the cells were transferred to 37°C for 3-h incubation. The activation of
MyD88-dependent and TRIF-dependent signaling pathways was monitored by measuring lev-
els of TNF-α and RANTES, respectively, in culture supernatants. Production of both TNF-α
Fig 3. S-LPS stimulates association of CD14 with CD36. (A) S-LPS at 1 μg/ml enhances binding of rCD36 to plate-adsorbed rCD14. (B) CD36-/- PEMs
exhibit neither basal nor 1 μg/ml S-LPS-stimulated rCD14 binding. (C) S-LPS-stimulated binding of rCD14 to PEMs is blocked by anti-CD36 mAb, but not by
anti-TLR2 or anti-TLR4/MD-2 mAb. (D) During 40 min co-incubation at 37°C, 200 ng/ml S-LPS stimulates much stronger rCD14 binding to PEMs than the
same concentration of R-LPS. Graphs showmeans ± SEM of 3–4 replicates, obtained in single experiments, each representative of at least 3 similar
experiments performed. Data on graphs C and D were analyzed with ANOVA, followed by the Dunnett’s post-test. *, p < 0.05; HRP-anti-Fc, HRP-conjugated
F(ab’)2 fragments of goat antibodies specific for Fc fragments of human IgG.
doi:10.1371/journal.pone.0153558.g003
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and RANTES was strictly CD14-dependent (Fig 4A), which is consistent with the observation
that under these conditions S-LPS binding to PEMs is selectively mediated by CD14 (Fig 1B).
In comparison to WT controls, in CD36-/-, but not in SR-A-/- PEMs S-LPS stimulated signifi-
cantly higher production of both cytokines (Fig 4B). These results indicate that CD36-mediated
sequestration of S-LPS/CD14 complexes partially prevents TLR4/MD-2 activation by S-LPS.
Higher binding of S-LPS to TLR4/MD-2 on CD36-/- as compared to WT PEMs has been
confirmed in experiments with clone MTS510 anti-TLR4/MD-2 mAb, which does not bind to
LPS-occupied TLR4/MD-2 [36]. Similarly as in our previous study on J774 macrophage-like
cells [37], only concentrations of S-LPS higher than 100 ng/ml caused down regulation of cell
surface TLR4/MD-2 expression, assessed with clone Sa15-21 anti-TLR4/MD-2 mAb (Fig 5A).
In contrast, binding of clone MTS510 mAb was dose-dependently inhibited by S-LPS. When
incubated with PEMs for 40 min at 37°C, 200 ng/ml S-LPS produced significantly stronger
inhibition of MTS-510 mAb binding to TLR4/MD-2 on CD36-/- than on WT PEMs (Fig 5B),
confirming that CD36-mediated internalization of S-LPS/CD14 complexes partially prevents
S-LPS transfer from CD14 onto TLR4/MD-2. The higher TLR4/MD-2 occupancy by S-LPS in
Fig 4. Effects of CD36 or SR-A deficiency and of anti-CD14 mAb on TNF-α and RANTES production, stimulated by 1-h incubation on ice with
1 μg/ml S-LPS (A-B) or R-LPS (C-D). (A) Anti-CD14mAb blocks both TNF-α and RANTES production, stimulated by S-LPS. (B) S-LPS stimulates
significantly higher cytokine production in CD36-/- than in WT or SR-A-/- PEMs. (C) R-LPS-stimulated cytokine production is more strongly inhibited by anti-
CD14 mAb in CD36-/- than in WT or SR-A-/- PEMs. (D) R-LPS stimulates similar cytokine production in WT, CD36-/- and SR-A-/- PEMs. Graphs show
means +SEM from 4–6 independent experiments, each performed in 4 replicates. Data on graphs A and C were analyzed with one-sample t-test, and on
graphs B and D with ANOVA, followed by the Dunnett’s test. *, p < 0.05.
doi:10.1371/journal.pone.0153558.g004
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Fig 5. Relative roles played by CD36 and CD14 in LPS loading onto TLR4/MD-2 and in LPS-stimulated cytokine production depend on the LPS
chemotype and the presence of serum. (A) Binding of mAbs to PEMs pre-incubated with the indicated concentrations of S-LPS. (B) Forty-min pre-
incubation at 37°C with 200 ng/ml S-LPS, but not with R-LPS in FCS-RPMI more strongly inhibits MTS510 mAb binding to TLR4/MD-2 on CD36-/- than on
WT PEMs. In contrast, in BSA-RPMI both S-LPS and R-LPS produce significant inhibition of MTS510 mAb binding only in WT PEMs. (C) Forty-min
stimulation in FCS-RPMI with 200 ng/ml S-LPS, but not with R-LPS induces significantly higher TNF-α production in WT than in CD36-/- PEMs (left panel). In
contrast, R-LPS, but not S-LPS stimulates significantly lower RANTES production in CD36-/- PEMs (right panel). In BSA-RPMI, CD36-/- PEMs exhibit severe
impairment of cytokine production in response to both S-LPS and R-LPS. (D) In both WT and CD36-/- PEMs cytokine production stimulated by 40-min
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CD36-/-, as compared to WT PEMs was paralleled by significantly higher TNF-α production
(Fig 5C, left panel).
PEMs expressed ~10-times more CD14 than TLR4/MD-2 on their surface (S5A Fig). The
expression of both receptors was not altered in CD36-/- relative to WT PEMs (S5B Fig), ruling
out the difference in expression levels of these receptors as a possible cause of the observed dif-
ferences in responsiveness to S-LPS. We have reported previously that also SR-A-/- PEMs
express similar levels of CD14 and TLR4/MD-2 as WT PEMs [19]. Consistent with our previ-
ous observations [34], PEMs expressed very high levels of CD36, ~4-fold higher than CD14,
and the expression of this receptor was not affected by SR-A deficiency (S5A Fig).
In serum-free medium, binding of S-LPS/CD14 complexes to CD36
promotes S-LPS transfer from CD14 onto TLR4/MD-2
As S-LPS binds much more strongly to rCD36 in serum-free than in serum-containing
medium, we assessed the role of CD36 in the regulation of macrophage activation by S-LPS
under the former conditions. In serum-free medium (BSA-RPMI), binding of S-LPS to TLR4/
MD-2 expressed on the surface of CD36-deficient PEMs was severely impaired (Fig 5B) and,
consequently, CD36-/- PEMs produced much less of both TNF-α and RANTES upon stimula-
tion with S-LPS than WT PEMs (Fig 5C). The observation that rCD36 has no effect on bS-LPS
binding to rCD14 (S3C Fig) indicates that CD36 does not indirectly facilitate S-LPS loading
onto TLR4/MD-2 by mediating disaggregation of S-LPS micelles and transfer of monomers to
CD14, in a manner analogous to LBP. Also the possibility of the direct S-LPS transfer from
CD36 to TLR4/MD-2 (omitting CD14) is excluded by the observation that in both WT and
CD36-/- PEMs cytokine production is strictly CD14-dependent (Fig 5D). In contrast, S-LPS
induced strong binding of rCD14 to CD36 on PEMs also in the absence of serum (Fig 3D).
When exposed to 20 ng/ml of monomeric S-LPS/rCD14 complexes, CD36-/- PEMs produced
~4-5-times less TNF-α and RANTES than WT PEMs (S6 Fig). These results indicate that
under serum-free conditions, association of S-LPS/CD14 complexes with CD36 promotes
S-LPS transfer from CD14 to TLR4/MD-2.
CD36 positively regulates activation of TRIF-dependent TLR4 signaling
by promoting internalization of LPS/TLR4/MD-2 complexes
Unlike in experiments involving pre-incubation on ice (Fig 4B), 40-min pre-incubation with
200 ng/ml S-LPS at 37°C stimulated similar RANTES production in WT and CD36-/- PEMs
(Fig 5C). These results might indicate that under conditions enabling endocytosis, decreased
stimulation of cell surface-localized TLR4/MD-2 in WT PEMs is compensated by CD36-me-
diated delivery of S-LPS/CD14 complexes into endosomes and activation of the TRIF-depen-
dent pathway by intracellular TLR4/MD-2 [38, 39]. However, this possibility is inconsistent
with the observation that blocking of cell surface-localized TLR4/MD-2 with MTS-510 mAb
inhibited S-LPS-stimulated RANTES production to a similar extent in WT and CD36-/- PEMs
(S7A Fig). Moreover, S-LPS-induced RATES production was completely blocked by dynamin
inhibition with hydroxy-dynasore (Fig 6A), which prevents activation of TRIF-dependent sig-
naling by cell surface-derived TLR4/MD-2 complexes, but has little or no effect on the recruit-
ment to endosomes/phagosomes and activation of intracellular TLR4/MD-2 [38]. Collectively,
incubation with 200 ng/ml S-LPS in serum-free medium is blocked completely by anti-CD14 mAb. Anti-CD14 mAb also blocks cytokine production stimulated
by R-LPS in CD36-/- PEMs, whereas it exerts only partial inhibition in WT PEMs. Data shown on graphs A and D are means +SEM of triplicates, obtained in
single experiments, which were performed 2 (A) or 3 (D) times with similar results. Graphs B-C showmeans +SEM from 4–6 independent experiments, each
performed in 4 replicates. *, significant inhibition or difference betweenWT and CD36-/- PEMs (p < 0.05 in Student’s t-test).
doi:10.1371/journal.pone.0153558.g005
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Fig 6. The role of endocytosis in LPS-induced intracellular signaling. (A) Hydroxy-dynasore (Dyn-OH) at 30 μM blocks RANTES, but enhances TNF-α
production, stimulated by 1-h incubation on ice with 1 μg/ml LPS. Cytochalasin D (Cyt-D) at 10 μM has no effect on RANTES, but inhibits TNF-α production.
(B, C) One μg/ml S-LPS (B) and R-LPS (C) produce stronger down-regulation of cell surface TLR4/MD-2 expression in WT than in CD36-/- PEMs. (D)
Internalization of CD14-bound bS-LPS/pHr-SAV complexes into acidic endosomes is blocked by both Dyn-OH and Cyt-D. A JNK inhibitor (JNKi) at 20 μM
produces stronger inhibition of the internalization in WT than in CD36-/- PEMs. (E) Seventy-min uptake of 10 μg/ml BO-LPS byWT PEMs is inhibited by Cyt-
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these results indicate the exclusive role of cell surface-derived TLR4/MD-2 in the stimulation
of RANTES production by S-LPS.
Alternatively, CD36 might be involved in the internalization of LPS/TLR4/MD-2 com-
plexes, which is required for the initiation of TRIF-dependent signaling. This possibility has
been confirmed by results shown in Fig 6B. Thirty-min incubation with 1 μg/ml S-LPS pro-
duced ~1.8-fold stronger down-regulation of TLR4/MD-2 expression on the surface of WT (by
~61%) relative to CD36-/- PEMs (~33%).
To assess the role of CD36 in regulating S-LPS-induced responses in vivo, WT and CD36-/-
mice were injected with 1 μg S-LPS i.p. and 90 min later sera were collected for cytokine deter-
mination. S-LPS induced on average ~1.8-fold higher serum levels of TNF-α in CD36-/- than
in WT mice (Fig 7A), indicating that the S-LPS-induced, MyD88-dependent TLR4 signaling is
subjected to the CD36-mediated negative regulation also in vivo. In contrast, serum levels of
IL-6, which production under these experimental conditions is more TRIF- than MyD88-de-
pendent [40] were not significantly affected by CD36 deficiency (Fig 7B).
Dynamin controls both internalization of CD14-bound S-LPS into acidic
endosomes and activation of the TRIF-dependent pathway of TLR4
signaling
The mechanisms of LPS endocytosis following its binding to CD14 have not been completely
elucidated. As CD14 is a GPI-anchored protein, LPS/CD14 complexes might be internalized
through the clathrin- and dynamin-independent, lipid raft-mediated pathway which depends
on Cdc42 GTPase-regulated polymerization of actin [41, 42]. In contrast, LPS/TLR4/MD-2
complexes have been reported to undergo dynamin-dependent internalization through cla-
thrin-coated pits [35, 43], which does not depend on the actin cytoskeleton [41, 44]. However,
actin has been reported to control the transfer of cargo internalized through both clathrin-
D, but enhanced by Dyn-OH. Graphs showmeans +SEM from 3–4 independent experiments, each performed in 3–4 replicates. *, significant inhibition
(significantly different (p < 0.05) from 100 in one-sample t-test) (A), significant difference betweenWT and CD36-/- PEMs (p < 0.05 in two-tailed t-test) (B, C,
D), or significantly different from the solvent control (p < 0.05 in ANOVA, followed by the Dunnett’s post-test) (E).
doi:10.1371/journal.pone.0153558.g006
Fig 7. S-LPS stimulates significantly higher serum levels of TNF-α in CD36-/- than in WTmice.Mice were i.p. injected with 1 μg S-LPS or R-LPS in 1 ml
BSA-PBS and 90 min later sera were collected for TNF-α and IL-6 determination by ELISA. Points represent cytokine concentrations in individual mice and
horizontal lines mean values. *, p < 0.05 in two-tailed t-test.
doi:10.1371/journal.pone.0153558.g007
CD36 Regulates Macrophage Responses to LPS
PLOSONE | DOI:10.1371/journal.pone.0153558 April 13, 2016 16 / 26
dependent and -independent pathways from early to late endosomes [45, 46]. To explore how
these steps might affect S-LPS interactions, we assessed effects of hydroxy-dynasore, a dyna-
min-selective inhibitor, and of cytochalasin D, an inhibitor of actin polymerization, on the
internalization into acidic endosomes of bS-LPS/pHr-SAV complexes. Internalization of these
complexes was blocked by both cytochalasin D and hydroxy-dynasore (Fig 6D). Pre-incuba-
tion with hydroxy-dynasore also blocked activation of TRIF-dependent signaling, as assessed
by RANTES production, while concomitantly enhancing MyD88-dependent signaling from
the cell surface, as reflected by increased TNF-α production (Fig 6A). In contrast, cytochalasin
D had no effect on RANTES production, but inhibited TNF-α production (Fig 6A), much
more strongly in response to S-LPS (~50%) than to R-LPS (~10%). These results are consistent
with a scenario in which, following dynamin-dependent internalization, S-LPS induces the
TRIF-dependent signaling in early endosomes and then undergoes actin-dependent transfer to
late endosomes/lysosomes.
CD36-medited endocytosis has been reported to depend on the activation of JNK [47]. The
JNK-selective inhibitor SP600125 produced significantly stronger inhibition of the internaliza-
tion of bS-LPS/pHr-SAV complexes in WT (~94%) than in CD36-/- (~56%) PEMs (Fig 6D),
suggesting that CD36-mediated internalization of these complexes also depends on JNK
activity.
Uptake of BO-LPS aggregates in WT PEMs was inhibited by ~40% by cytochalasin D and
enhanced ~2-fold by hydroxy-dynasore (Fig 6E). The enhancing effect of hydroxy-dynasore
may indicate that blocking of clathrin-dependent endocytosis causes compensatory up-regula-
tion of clathrin-independent pathways, which are involved in BO-LPS uptake, as has been
observed previously [27]. On the other hand, an incomplete inhibition of BO-LPS uptake by
cytochalasin D may result from the partial re-direction of BO-LPS uptake to the clathrin-medi-
ated pathway [48].
CD36 and CD14 independently mediate R-LPS loading onto TLR4/MD-
2
Unlike in the case of S-LPS (Fig 4B), WT and CD36-/- PEMs produced similar amounts of
TNF-α and RANTES upon pre-incubation with R-LPS (Fig 4D). However, effects of CD14
blockade have revealed differences between these strains of PEMs. Whereas anti-CD14 mAb
inhibited TNF-α production in CD36-/- PEMs by half, it had no effect in WT and SR-A-/-
PEMs (Fig 4C). Likewise, this mAb produced almost complete, ~87% inhibition of R-LPS-
stimulated RANTES production in CD36-/- PEMs, but only less than 35% inhibition in WT or
SR-A-/- PEMs (Fig 4C). The observation that anti-CD14 mAb inhibits R-LPS-stimulated
TNF-α production only in CD36-/- PEMs indicates that in WT macrophages CD36 may
replace CD14 in R-LPS loading onto TLR4/MD-2. The stronger effect of anti-CD14 mAb on
R-LPS-stimulated RANTES than TNF-α production may be explained by the additional role
played by CD14 in the activation of TRIF-dependent pathways [10–12].
In addition, stimulation with R-LPS at 37°C led to similar TNF-α production in WT and
CD36-/- PEMs (Fig 5C), consistent with similar binding of R-LPS to TLR4/MD-2 in both
strains of PEMs (Fig 5B). Likewise, CD36 deficiency had no effect on the production of TNF-α,
stimulated by 1 μg of R-LPS in vivo (Fig 7A). Thus, in contrast to S-LPS, R-LPS binding to
TLR4/MD-2 does not seem subject to CD36-mediated negative regulation, likely because
R-LPS is ineffective in stimulating CD14 association with CD36 (Fig 3D). In contrast, activa-
tion of the TRIF pathway by R-LPS was severely impaired in CD36-/- PEMs, as indicated by
~44% lower production of RANTES (Fig 5C). Similar to the case of stimulation with S-LPS,
this impairment may be explained by the role of CD36 in mediating internalization of R-LPS/
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TLR4/MD-2 complexes. R-LPS produced ~3-times weaker down-regulation of surface TLR4/
MD-2 in CD36-/- (~10%) than in WT (~31%) PEMs (Fig 6C).
As LPS binding to CD14 is facilitated by LBP from serum and, conversely, serum decreases
LPS binding to CD36, we postulated that the absence of serum would increase the role of CD36
as a R-LPS receptor. Indeed, under serum-free conditions CD36-/- PEMs exhibited severe
impairment of R-LPS binding to TLR4/MD-2 (Fig 5B) as well as of R-LPS-stimulated TNF-α
(~35% reduction) and RANTES (~40%) production (Fig 5C). Whereas anti-CD14 mAb abol-
ished R-LPS-stimulated cytokine production in CD36-/- PEMs, it produced only partial inhibi-
tion in WT PEMs (Fig 5D). Thus, unlike in serum-containing medium, in serum-free medium
the role of CD36 in R-LPS loading onto TLR4/MD-2 could not be fully compensated by CD14.
The complete blockade of R-LPS-induced responses by anti-CD14 mAb in CD36-/- PEMs (Fig
5D) also indicates that CD36 and CD14 are the only receptors mediating R-LPS loading onto
TLR4/MD-2. Moreover, the additivity of effects of CD36 deficiency and of anti-CD14 mAb
indicates that CD36 and CD14 mediate R-LPS loading onto TLR4/MD-2 independently of
each other.
R-LPS and S-LPS differ in their affinities for LBP, CD14 and CD36
Differences in relative roles played by CD36 and CD14 in macrophage responses to R-LPS ver-
sus S-LPS may be explained by differences in binding affinities. As shown in Fig 8A, S-LPS
competed with bS-LPS binding to rCD14 much more effectively than R-LPS, with IC50 values
of ~0.2 and 2.6 μg/ml, respectively. Corresponding inhibition constant values, calculated on
the basis of the KD value of bS-LPS binding determined in saturation experiments (S2A Fig)
and average molecular weights of S-LPS and R-LPS (15.8 kDa [49] and 4 kDa [50], respec-
tively), were 3.8 ± 0.36 nM, in the case of S-LPS, and 650 ± 82.5 nM, in the case of R-LPS. Like-
wise, rLBP bound R-LPS with a lower affinity than S-LPS (Fig 8B). Whereas S-LPS produced
significant inhibition of bS-LPS binding to rLBP already at 100 ng/ml, R-LPS had no effect
even at 10-fold higher concentrations. These differences in affinities correlated with the ability
of rCD14 or rLBP to sensitize PEMs to low concentrations of LPS in serum-free medium.
Whereas TNF-α production stimulated by 5 ng/ml S-LPS was enhanced ~200-fold by rLBP
and ~50-fold by rCD14 (Fig 8E), that stimulated by 5 ng/ml R-LPS was only increased
~3-times by rLBP and not significantly affected by rCD14 (Fig 8F). S-LPS- or R-LPS-stimulated
RANTES production was regulated by rLBP and rCD14 in a similar manner as TNF-α produc-
tion (Fig 8E and 8F). Interestingly, the combination of rLBP and rCD14 exerted a synergistic
effect on cytokine production stimulated by R-LPS (Fig 8F), but did not produce stronger
enhancement of S-LPS-stimulated cytokine production than rLBP alone (Fig 8E).
Conversely, R-LPS turned out to be a higher affinity ligand of CD36 than S-LPS, as indi-
cated by relative potencies in inhibiting rCD36 binding to plate-adsorbed GA-BSA (Fig 8C). A
higher affinity of rCD36 to R-LPS, as compared to S-LPS, has been confirmed in direct binding
experiments (Fig 8D). rCD36 bound to plate-adsorbed R-LPS with ~60-times higher affinity
(KD = 0.28 ± 0.057 μg/ml, corresponding to 3.8 ± 0.78 nM) than to adsorbed S-LPS (KD =
17.6 ± 1.25 μg/ml or 241 ± 17.1 nM). rCD36 binding to LTA, used as a positive control,
occurred with an intermediate KD of 4.4 ± 0.30 μg/ml (60 ± 4.1 nM).
Discussion
Our experiments have revealed a complex role for CD36 in regulating macrophage responses
to LPS, which depends on the chemotype of LPS, its concentration and the presence of serum.
In serum-containing medium, CD36 contributes to the internalization of S-LPS/CD14 com-
plexes, which competitively decreases S-LPS transfer from CD14 onto the cell surface-localized
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TLR4/MD-2 and, consequently, reduces activation of MyD88-dependent signaling. By con-
trast, under serum-free conditions, association of S-LPS/CD14 with CD36 might promote
S-LPS transfer from CD14 to TLR4/MD-2 and activation of TLR4-induced intracellular signal-
ing by increasing the probability of S-LPS/CD14 encounters with TLR4/MD-2. In macrophage
membranes, diffusion of a fraction of CD36 is limited to linear confinement regions, which
enhances the probability of collisions between receptors. De-polymerization of F-actin was
found to markedly reduce the fraction of linearly moving CD36, leading to suppression of
receptor clustering and of CD36-mediated signaling [51]. This postulated mechanism may be
expected to play a significant role only under conditions when low density of S-LPS/CD14
complexes is the limited factor in the activation of TLR4/MD-2. Indeed, relative to WT PEMs,
CD36-/- PEMs produced by ~72% less TNF-α in response to 20 ng/ml of complexes of mono-
meric S-LPS with rCD14, but only by ~11% less TNF-α in response to 10-times higher concen-
tration of these complexes (S6 Fig). In addition, there was no difference in cytokine production
between WT and CD36-/- PEMs when high concentrations of S-LPS were used for stimulation
in serum-free medium (S7C Fig). Thus, CD36 may mediate a fine-tuning of macrophage
responses to S-LPS. By increasing the sensitivity of macrophages to S-LPS, CD36 might enable
Fig 8. S-LPS and R-LPS bind to LBP, CD14 and CD36 with different affinities. (A) 200 ng/ml bS-LPS binding to plate-adsorbed rCD14 is more effectively
inhibited by S-LPS than R-LPS. (B) S-LPS is a more efficient competitor than R-LPS in inhibiting bS-LPS binding to plate-adsorbed rLBP. (C) Lower
concentrations of R-LPS than S-LPS are required to inhibit rCD36 binding to plate-adsorbed GA-BSA. (D) rCD36 binds with higher affinity to plate-adsorbed
R-LPS than to S-LPS or LTA. (E) Cytokine production stimulated by 5 ng/ml S-LPS in serum-free medium is strongly enhanced by 0.2 μg/ml rLBP and, to a
lesser extent, by 2 μg/ml rCD14. (F) Only the combination of rLBP and rCD14 enhances cytokine production in response to 5 ng/ml R-LPS. Graphs show
means ± SEM of 3–4 replicates, obtained in single experiments, performed twice with similar results. Data were analyzed with two-tailed and one-sample t-
test (B and C) or with ANOVA, followed by the Tukey-Kramer test (E and F); *, p < 0.05.
doi:10.1371/journal.pone.0153558.g008
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detection of fewer bacteria and, consequently, generation of a faster response to infection. On
the other hand, in later phases of infection, following leakage of serum to the infection site, the
CD36-mediated negative regulation may prevent an excessive production of pro-inflammatory
cytokines, thereby protecting from septic shock.
Of note, CD36-/- PEMs produced significantly more TNF-α than WT cells when subjected
to a brief stimulation with S-LPS, but not when S-LPS was continuously present during the
entire period of the 3.5-h culture (S7B Fig). The observation that in CD36-/- mice S-LPS
induced significantly higher serum levels of TNF-α indicates that the former conditions may
better mimic the situation in vivo, likely because operating in vivo re-distribution, clearance,
neutralization and detoxification processes may lead to rapid decrease of LPS concentration/
bioactivity.
In contrast, CD36 deficiency had no effect on S-LPS-induced activation of the TRIF-depen-
dent pathway, which mediates the adjuvant effect of LPS on adaptive immunity [52], likely
because the enhancement of TLR4 signaling caused by increased S-LPS binding to cell surface-
localized TLR4/MD-2 had been countered by the impaired internalization of S-LPS/TLR4/
MD-2 complexes. This positive role of CD36 in the regulation of TRIF-dependent signaling
was more evident in the case of R-LPS, as R-LPS binding to TLR4/MD-2 was not subjected to
the CD36-mediated negative regulation. Relative to WT PEMs, in CD36-/- PEMs internaliza-
tion of TLR4/MD-2 caused by R-LPS was decreased by ~68%, and RANTES production was
reduced by ~44%.
CD14 has been reported to mediate internalization of TLR4/MD-2 complexes indepen-
dently of TLR4 signaling [10–12], but it has remained unclear how CD14 is linked to the endo-
cytic machinery and intracellular signaling, as it lacks both transmembrane and intracellular
domains. In this study, we have identified CD36 as a receptor which may provide a transmem-
brane link for CD14. We have found that CD36 is the only macrophage surface component
that binds rCD14. Moreover, internalization of both S-LPS/CD14 and LPS/TLR4/MD-2 com-
plexes are impaired in CD36-/- macrophages. The role of CD36 as a transmembrane link for
CD14 is further supported by observations that the Syk kinase, the phospholipase Cγ2 and an
immunoreceptor tyrosine-based activation motif (ITAM)-containing adaptor proteins are
involved in both CD14-dependent internalization of TLR4/MD-2 complexes [11, 12] and in
CD36-mediated endocytosis [53] and that complexes of CD36 with its ligands undergo actin-
dependent internalization into endosomal structures in which CD36 co-localizes with GPI-
anchored proteins [47, 54].
The detailed mechanisms of CD36 involvement in both S-LPS/CD14 and LPS/TLR4/MD-2
endocytosis remain to be elucidated. As pHr exhibits bright fluorescence only in strongly acidic
pH, with the use of this dye we might preferentially measure the fraction of LPS uptake which
is directed into late endosomes/lysosomes. The complete blockade of bS-LPS/pHr-SAV inter-
nalization by hydroxy-dynasore may indicate that, during this short incubation, only the por-
tion of LPS internalized through clathrin-coated pits, including bS-LPS transferred from CD14
onto TLR4/MD-2, reaches lysosomes [35, 43]. Internalization of bS-LPS/pHr-SAV complexes
was decreased by half in CD36-/- PEMs, indicating a positive regulatory role of CD36 in this
process. In contrast, GPI-anchored proteins internalized through clathrin-independent, lipid
raft-dependent pathways have been shown to be mainly recycled back to the plasma membrane
[42, 46, 48, 55]. The observed kinetics of LPS uptake in monocytes-macrophages is consistent
with the possibility that a large portion of endocytosed LPS is recycled. We have found that
PEM-mediated clearance from the culture medium of unlabeled LPS within 40 min reaches the
maximal value of ~50% of its initial concentration and is not further increased by extending
the incubation up to 2 h [19]. In CD14-transfected monocytic THP-1 cells internalization of
membrane CD14-bound tritiated LPS reached plateau within 30–60 min, when only ~55% of
CD36 Regulates Macrophage Responses to LPS
PLOSONE | DOI:10.1371/journal.pone.0153558 April 13, 2016 20 / 26
these complexes was internalized [56]. CD36 seems to be also involved in this clathrin-inde-
pendent endocytosis of LPS by PEMs, as indicated by a significant impairment of BO-LPS
uptake in CD36-/- PEMs, and by observed in our previous study strong inhibition exerted by
anti-CD36 mAb on native LPS clearance from the culture medium by PEMs [19].
Our study has also revealed that, like CD14, CD36 differently regulates macrophage
responses to S-LPS versus R-LPS and that these two receptors play complementary roles. Most
importantly, it clarifies previously unexplained observations that activation of MyD88-depen-
dent pathways of TLR4 signaling by S-LPS, but not by R-LPS exhibits strict CD14-dependence.
The apparent CD14-independence of macrophage activation by R-LPS results from the ability
of CD36 to substitute for CD14 in R-LPS loading onto TLR4/MD-2. CD14 and CD36 seem to
mediate R-LPS loading onto TLR4/MD-2 independently of each other. This contrast with the
mechanism of the facilitating effect of CD36 on S-LPS binding to TLR4/MD-2 in serum-free
medium, a process which is entirely CD14-dependent. Moreover, the blockade of R-LPS-stim-
ulated responses in CD36-/- PEMs by anti-CD14 mAb in serum-free (Fig 5D) and almost com-
plete inhibition in serum-containing medium (S7D Fig) indicate that CD36 and CD14 may be
the only accessory receptors mediating R-LPS loading onto TLR4/MD-2.
Differential involvement of LBP, CD14 and CD36 in macrophage activation by R-LPS ver-
sus S-LPS might be explained by the large differences in binding affinities found in our study.
Applying a different approach, we have confirmed the previously suggested mechanism of LBP
and CD14 cooperation in LPS loading onto TLR4/MD-2, involving LBP-catalyzed extraction
of monomers from LPS micelles and their transfer to CD14 [8]. Our novel finding is that
S-LPS transfer between LBP and CD14 is reversible, which is made possible by similar affinities
of S-LPS for both proteins. rLBP and rCD14 bound S-LPS with much higher affinities than
R-LPS. LPS binding to CD14 seems to be mainly mediated by the hydrophobic cavity present
in its N-terminal part, which may accommodate some of acyl chains of lipid A [57]. The higher
affinity of S-LPS for CD14 might result from the fact that, unlike in the case of R-LPS, S-LPS
binding to CD14 additionally involves binding of the O-antigen to the grooves present outside
this hydrophobic pocket [57, 58]. In addition to differences in binding affinities, differences in
the structure of micelles formed by R-LPS and S-LPS might be partially responsible for the
observed differences in the effectiveness of LBP and CD14 in functioning as accessory proteins
for different LPS chemotypes. S-LPS may be much more available for receptors compared to
R-LPS because the hydrophilic O-antigen can act as a water-solubilizing carrier for lipid A,
which might explain the observation that despite the fact that commercial preparations of
nominally smooth LPS, as this used in our study, usually contain variable amounts of R-LPS
[59], effects of contaminating R-LPS in such S-LPS preparations are never apparent. Consistent
with this interpretation, rLBP alone was sufficient to produce the maximal enhancement of
macrophage responses to S-LPS, but the combined action of rLBP and rCD14 was required to
produce disaggregation of R-LPS.
Conversely, rCD36 bound R-LPS with higher affinity than S-LPS. An essential property of
SR ligands is their net negative charge. Negative charge is conferred on LPS molecules by phos-
phate groups, which esterify positions 1 and 4’ of the diglucosamine backbone of lipid A and
some heptulose or KDO residues in the inner core oligosaccharide, and by carboxylic groups of
KDOs [50]. Thus, the lower affinity of S-LPS for CD36, relative to R-LPS, may result from
lower density of negative charges in S-LPS micelles, caused by the attachment of uncharged O-
antigens, which account for as much as 67–78% of the total molecular weight of S-LPS [59].
Our findings that relative to S-LPS, R-LPS exhibits lower affinity for CD14, but higher affinity
for CD36 may explain previous observations that with the reduction of the size of its saccharide
part, the potency of LPS to activate CD14+/+ macrophages decreases, but responses of
CD14-/- macrophages are enhanced [60].
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In order to be able to bind to SR-A with high affinity, ligands need to have an even stronger
negative charge than that sufficient to confer a high-affinity binding to CD36 [34, 61]. Thus,
concentration of negative charges associated with phosphorylated diglucosamine and the inner
core oligosaccharide on the surface of lipid A or Re-LPS micelles may enable their binding to
SR-A [20–22]. In contrast, masking of these negative charges by the attached uncharged sac-
charides of the outer core and the O-antigen in S-LPS micelles seems to prevent their binding
to SR-A, as we have found that SR-A does not serve as either a binding or a signaling receptor
for S-LPS. Binding to SR-A of fluorescent S-LPS conjugates, observed in other studies [25–27],
was likely mediated by the attached, negatively-charged fluorochromes rather than by S-LPS
itself.
Our studies have identified surprising complexity in the interaction of LPS chemotypes with
macrophage receptors and signal transduction machinery. The data explain prior confounding
results, and also suggest a biologic basis for variability in the timing and strength of macro-
phage activation at infection sites that differ in availability of serum and in LPS chemotypes
released.
Supporting Information
S1 Fig. Binding of bS-LPS (A, B) and rCD14 (C) to PEMs. (A) CD36 and SR-A deficiencies
have no effect on 1-h bS-LPS biding at 37°C to metabolically-poisoned PEMs in either serum-
free or serum-containing medium. (B) Binding of 200 ng/ml bS-LPS to WT PEMs on ice is
blocked by a 200-fold excess of unlabeled S-LPS. (C) 1 μg/ml S-LPS stimulates higher rCD14
binding to PEMs at 0°C than at 37°C.
(TIF)
S2 Fig. bS-LPS binding to recombinant receptors. (A) Binding of bS-LPS to plate-adsorbed
rCD14 is much higher than that to rCD36. Serum strongly increases level of bS-LPS binding to
rCD14 without altering its affinity. (B) The kinetics of bS-LPS binding to rCD14 is much
slower in BSA-PBS than in FCS-PBS. (C) The inclusion of 200 ng/ml rLBP in BSA-PBS
increases bS-LPS binding to rCD14. (D) bS-LPS binds dose-dependently to rLBP. (E) 200 ng/
ml rLBP produces already the maximal acceleration of bS-LPS binding to rCD14.
(TIF)
S3 Fig. rCD36 binds bS-LPS specifically, but does not facilitate bS-LPS binding to rCD14
(A) Anti-CD36 mAb inhibits bS-LPS binding to rCD36 in BSA-PBS. (B) rCD36 and rCD14
exhibit similar adsorption to plates. (C) Soluble rCD36 has no effect on bS-LPS binding to
adsorbed rCD14 in BSA-PBS.
(TIF)
S4 Fig. CD36 contributes to S-LPS uptake by PEMs, whereas the binding of fluorescent
S-LPS conjugates to SR-A is mediated by fluorophores. (A) Both CD36- and SR-A-deficient
PEMs exhibit significant impairment of 70-min AF-LPS uptake. (B) Uptake of 1 μg/ml AF-LPS
by PEMs is strongly inhibited by 100 μg/ml DS, but unaffected by 250-fold excess of unlabeled
S-LPS. (C) Metabolic poisoning blocks internalization of pHr-labeled, HOCl-oxidized ovalbu-
min (pHr-OVA-Cl) into acidic endosomal compartments. (D) Two-h uptake of AF-LPS by
PEMs is not saturable. (E) Binding and uptake of BO-LPS is significantly decreased in CD36-/-
, but not in SR-A-/- PEMs. (F) Unlabeled S-LPS only partially inhibits BO-LPS uptake by
PEMs. Graphs A-B and E-F show means +SEM from 4–7 independent experiments. Graphs C
and D show means +SEM of 4 replicates in a single experiment, which was performed twice
with similar results. Data were analyzed with the repeated measures ANOVA, followed by the
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Dunnett’s post-test. , p< 0.05; MFI, mean fluorescence intensity; ND, not done.
(TIF)
S5 Fig. WT, CD36-/- and SR-A-/- PEMs express TLR4/MD-2 and CD14 at similar levels.
(A) Expression of the indicated receptors on WT and SR-A-/- PEMs was determined by cellu-
lar ELISA. Amounts of HRP-conjugated, secondary Abs bound to cells were read from stan-
dard curves and specific binding calculated by subtracting binding of isotype-matched control
mAb from the total binding of receptor-specific mAb. (B) Expression of receptors on CD36-/-
PEMs was assessed by cellular ELISA and expressed as % of expression in WT PEMs. The data
shown are averages +SEM from the indicated number (N) of independent experiments.
(TIF)
S6 Fig. CD36-/- PEMs exhibit impaired cytokine production in response to low concentra-
tions of pre-formed monomeric S-LPS/rCD14 complexes in serum-free medium.
(TIF)
S7 Fig. Roles of CD36, CD14 and TLR4/MD-2 in LPS-stimulated cytokine production by
PEMs. (A) In serum-containing medium, RANTES production stimulated by 40-min incuba-
tion with 20 ng/ml S-LPS is inhibited by anti-TLR4/MD-2 MTS510 mAb to a similar extent in
WT and CD36-/- PEMs. (B) Continuous, 3.5-h stimulation with S-LPS induces similar TNF-α
production in WT and CD36-/- PEMs. The data shown are means +/- SEM from 7 indepen-
dent experiments. (C) In serum-free medium, CD36-/- PEMs produce less cytokines thanWT
controls in response to low, but not high concentrations of S-LPS (D) Cytokine production,
stimulated by 40-min incubation with R-LPS in FCS-RPMI is inhibited by anti-CD14 mAb
more strongly in CD36-/- than WT PEMs.
(TIF)
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